Delivery Order SPE2DB20D2104-SPE2DB23FS91Q

Award Date 4/4/23
Potential Completion Date 4/5/23
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
This federal contract award, valued at $6,052.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Plaquenil 200 mg tablets in 100-count bottles. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets in 100-count packages. The contract has a firm fixed price and a ceiling value of $33,529.91. It was awarded on January 15, 2025, with an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,101.97 firm fixed-price delivery order is for the pharmaceutical product Plaquenil 200 mg Tablet, with a completion date of June 5, 2023. The contract was awarded on June 2, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,115.34 firm fixed-price delivery order is for the supply of PLAQUENIL 200 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM7N8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,331.26, is a Delivery Order for the supply of Plaquenil 200 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of February 19, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $14,841.40 and runs through February 22, 2023. It is a firm-fixed-price delivery order, with no set-aside designation,...
This contract award, with ID SPE2DB20D3103|SPE2DB23FN9L4, is for the delivery of Plaquenil 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $73,336.81 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 10, 2023, with a completion date of July 11, 2023. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $113,239.37 and is a Firm Fixed Price contract type, with an ultimate completion date of August 22, 2024. The contract was...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FS91Q
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,706.79 delivery order contract is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of April 5, 2023 and is a firm fixed price arrangement.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:40 PM